Targeting PI3Kδ and PI3Kγ signalling disrupts human AML survival and bone marrow stromal cell mediated protection
Open Access
- 11 May 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (26) , 39784-39795
Abstract
Targeting PI3K and PI3K signalling disrupts human AML survival and bone marrow stromal cell mediated protectionKeywords
This publication has 37 references indexed in Scilit:
- PKCβ Phosphorylates PI3Kγ to Activate It and Release It from GPCR ControlPLOS Biology, 2013
- The high Nrf2 expression in human acute myeloid leukemia is driven by NF-κB and underlies its chemo-resistanceBlood, 2012
- Common and Overlapping Oncogenic Pathways Contribute to the Evolution of Acute Myeloid LeukemiasCancer Research, 2011
- Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100Blood, 2009
- Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AMLBlood, 2009
- The level of AKT phosphorylation on threonine 308 but not on serine 473 is associated with high-risk cytogenetics and predicts poor overall survival in acute myeloid leukaemiaLeukemia, 2009
- Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathwayLeukemia, 2007
- Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22)Leukemia, 2005
- PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kB, MAPkinase and p53 pathwaysLeukemia, 2005
- Constitutive activation of STAT transcription factors in acute myelogenous leukemiaEuropean Journal of Haematology, 2001